PRECISION OPTICS CORPORATION, INC. Goodwill and Intangible Asset Impairment
PRECISION OPTICS CORPORATION, INC. (POCI) reported Goodwill and Intangible Asset Impairment of $0 for the 12-month period ending 2025-06-30, per its 10-K filed 2025-09-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:GoodwillAndIntangibleAssetImpairment · last filed 2025-09-29
- PRECISION OPTICS CORPORATION, INC. goodwill and intangible asset impairment for the quarter ending 2025-06-30 was $0.00.
- PRECISION OPTICS CORPORATION, INC. goodwill and intangible asset impairment for the quarter ending 2025-03-31 was $0.00.
- PRECISION OPTICS CORPORATION, INC. goodwill and intangible asset impairment for the quarter ending 2024-12-31 was $0.00.
- PRECISION OPTICS CORPORATION, INC. goodwill and intangible asset impairment for the quarter ending 2024-09-30 was $0.00.
- PRECISION OPTICS CORPORATION, INC. goodwill and intangible asset impairment for fiscal 2025 was $0.00.
- PRECISION OPTICS CORPORATION, INC. goodwill and intangible asset impairment for fiscal 2024 was $0.00.
- PRECISION OPTICS CORPORATION, INC. goodwill and intangible asset impairment for fiscal 2023 was $0.00.
| Period end | Goodwill and Intangible Asset Impairment 3 month | Goodwill and Intangible Asset Impairment 6 month | Goodwill and Intangible Asset Impairment 9 month | Goodwill and Intangible Asset Impairment 12 month |
|---|---|---|---|---|
| 2025-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-29 | $0.00 derived: sum of 2 quarters · filed 2025-09-29 | $0.00 derived: sum of 3 quarters · filed 2025-09-29 | $0.00 10-K · filed 2025-09-29 |
| 2025-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-15 | $0.00 derived: sum of 2 quarters · filed 2025-05-15 | $0.00 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-13 | $0.00 10-Q · filed 2025-02-13 | ||
| 2024-09-30 | $0.00 10-Q · filed 2024-11-14 | |||
| 2024-06-30 | $0.00 10-K · filed 2025-09-29 | |||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-14 | |||
| 2023-06-30 | $0.00 10-K · filed 2024-09-30 | |||
| 2022-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-14 | $0.00 10-Q · filed 2023-02-14 | ||
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 | |||
| 2022-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-16 | $0.00 derived: sum of 2 quarters · filed 2022-05-16 | $0.00 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-14 | $0.00 10-Q · filed 2022-02-14 | ||
| 2021-09-30 | $0.00 10-Q · filed 2021-11-15 | |||
| 2021-03-31 | $0.00 10-Q · filed 2021-05-13 | $0.00 derived: sum of 2 quarters · filed 2021-05-13 | $0.00 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $0.00 10-Q · filed 2021-02-16 | $0.00 10-Q · filed 2021-02-16 | ||
| 2020-09-30 | $0.00 10-Q · filed 2020-11-12 | |||
| 2020-03-31 | $0.00 10-Q · filed 2020-05-14 | $0.00 derived: sum of 2 quarters · filed 2021-02-16 | $0.00 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $0.00 10-Q · filed 2021-02-16 | $0.00 10-Q · filed 2021-02-16 | ||
| 2019-09-30 | $0.00 10-Q · filed 2019-11-14 | |||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-14 | $0.00 derived: sum of 2 quarters · filed 2020-05-14 | $0.00 10-Q · filed 2020-05-14 | |
| 2018-12-31 | $0.00 10-Q · filed 2020-02-13 | $0.00 10-Q · filed 2020-02-13 | ||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |